Vir Biotechnology, Inc. (VIR) has seen some recent action in the market and its shares were last quoted at $38.89 yesterday. Traders are starting to take interest of VIR as the shares traded as high as $42.89 and as low as $36.08 in the last market trading day.

Vir Biotechnology, Inc. (VIR) average trading volume is 1.38M. However, in the last market trading day Vir Biotechnology, Inc. (VIR) traded 2,812,367 shares. The First downside support level on VIR is $35.63 and the First resistance level on VIR is $71.15. VIR 50 day moving average is $34.08 and VIR 200 day moving average is $27.55.

Vir Biotechnology, Inc. (VIR) most recent performance has been indicated by the recent movement in VIR shares. VIR has performed 4.94% over the past 30 days, VIR has performed 6.23% over the past 3 months and VIR has shown – over the past 12 months. Vir Biotechnology, Inc. (VIR) has a 52 week range of $11.65 to $75.00. Vir Biotechnology, Inc. (VIR) is trading 233.81% from its 52 week low and -48.15% from its 52 week high. Vir Biotechnology, Inc. (VIR) is showing a 2.06% short float showing the quantity short in the float.

VIR has 108.39M shares outstanding and 99.63M shares in the float. Vir Biotechnology, Inc. (VIR) presently has a market cap of $4.13B and income of -223.30M. The EPS next quarter for VIR is -0.62 and projected EPS next year is 8.20%. The market cap of Vir Biotechnology, Inc. (VIR) at $4.13B represents how many Traders own shares of VIR and is based off the last price ($38.89) of VIR and the quantity of shares outstanding (108.39M) with Vir Biotechnology, Inc. (VIR).

Vir Biotechnology, Inc. (VIR) has aggregate cash (mrq) of 355.61M, aggregate cash per share (mrq) of 3.02, aggregate debt of VIR rests at 17.74M and aggregate debt/equity (mrq) is 4.66. . Vir Biotechnology, Inc. (VIR) running cash flow (ttm) is -148.55M, VIR leveraged free cash flow (ttm) is -112.21M.

VIR is trading 11.21% above (bullish) its SMA20, 18.54% above (bullish) its SMA50 and 59.49% above (bullish) its SMA200.